S'abonner

Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries : Results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART) - 28/08/11

Doi : 10.1016/S0002-8703(03)00080-2 
Laura Mauri, MD, MS b, c, f, Mark Reisman, MD a, Maurice Buchbinder, MD e, Jeffrey J Popma, MD c, Samin K Sharma, MD d, Donald E Cutlip, MD f, g, Kalon K.L Ho, MD, MSc f, g, Ross Prpic, MD f, Peter J Zimetbaum, MD f, g, Richard E Kuntz, MD, MSc b, c, f,
a Swedish Hospital, Seattle, Wash,, USA 
b Clinical Biometrics, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass, USA 
c Cardiovascular Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass, USA 
d Mt Sinai Hospital, New York, NY, USA 
e Scripps Memorial Hospital, La Jolla, Calif, USA 
f Harvard Clinical Research Institute, Boston, Mass, USA 
g Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass, USA 

*Reprint requests: Richard E. Kuntz, MD, MSc, Division of Clinical Biometrics, Brigham and Women’s Hospital, 75 Francis St, Boston MA 02115, USA.

Abstract

Background

The optimum treatment of obstructive coronary disease in small (<3.0 mm diameter) arteries remains unknown. Rotational atherectomy is an approved treatment that might reduce the vascular injury during percutaneous coronary intervention compared with angioplasty. We report on a multicenter, randomized, blinded end point trial comparing rotational atherectomy with balloon angioplasty in the prevention of restenosis of obstructed small coronary arteries.

Methods

A total of 446 patients with myocardial ischemia associated with an angiographic stenosis in a native coronary artery 2 to 3 mm in diameter and ≤20 mm in length without severe calcification were randomly assigned to receive rotational atherectomy (n = 227) or balloon angioplasty (n = 219). The primary end point was target vessel failure at 12 months (defined as the composite of death, Q-wave myocardial infarction, and clinically driven repeat revascularization of the target vessel).

Results

The mean reference vessel diameter was 2.46 ± 0.40 mm, the mean lesion length was 9.97 ± 5.59 mm, and the prevalence of diabetes mellitus was 32%. Acute procedural success (91.6% for rotational atherectomy, 94.1% for balloon angioplasty, P = .36) and target vessel failure at 12 months were not significantly different (30.5% vs 31.2%, P = .98). At 8 months, there were no significant differences in minimum lumen diameter (1.28 ± 0.63 mm vs 1.19 ± 0.54 mm, P = .26), percent diameter stenosis (28% ± 12% vs 29% ± 15%, P = .59), binary restenosis rate (50.5% vs 50.5%, P = 1.0), or late loss index (0.57 vs 0.62, P = .7). No Q-wave myocardial infarctions occurred in either arm of the study, and non–Q-wave myocardial infarctions (defined as creatine kinase level >2 times normal with an elevated creatine kinase-myocardial band isoenzyme level) occurred in 2.2% and 1.4% of the patients in the rotational atherectomy and balloon angioplasty groups, respectively (P = .72).

Conclusion

Rotational atherectomy was found to be safe in the treatment of obstructed small arteries, but lower rates of target vessel failure were not achieved compared with balloon angioplasty. Because the acute gain and loss index ratios of the 2 treatments were similar, there was no evident beneficial antirestenosis mechanism seen for rotational atherectomy.

Le texte complet de cet article est disponible en PDF.

Plan


 Supported by Boston Scientific Interventional Technologies, Natick, Mass.


© 2003  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 145 - N° 5

P. 847-854 - mai 2003 Retour au numéro
Article précédent Article précédent
  • Comparison of acute changes in left ventricular volume, systolic and diastolic functions, and intraventricular synchronicity after biventricular and right ventricular pacing for heart failure
  • Cheuk-Man Yu, Hong Lin, Wing-Hong Fung, Qing Zhang, Shun-Ling Kong, John E Sanderson
| Article suivant Article suivant
  • Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction
  • Lech Polo?ski, Mariusz Gåsior, Jaros?aw Wasilewski, Krzysztof Wilczek, Andrzej Wn?k, E.l?bieta Adamowicz-Czoch, MD, Jacek Sikora, Andrzej Lekston, Tadeusz Z?bik, Marek Gierlotka, Rafa? Wojnar, Janusz Szkodzi?ski, Marek Kondys, B.o?ena Szygu?a-Jurkiewicz, Robert Wo?k, Marian Zembala

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.